Abstract
With the sequential use of dialysis, chromatography on Sephadex G-100, reactive red 120-agarose, p-hydroxymercuribenzoate-agarose, phenyl-Sepharose, poly(L-lysine)-agarose, and isoelectrofocusing, the thymocyte stimulatory factor activity of interleukin 2 from rat spleen was purified about 8,000-fold. By the same procedures, the T cell growth factor activity of interleukin 2 was purified about 6,000-fold. The major peaks of thymocyte stimulatory factor activity and T cell growth factor activity cochromatographed in the various systems used, but T cell growth factor activity without significant thymocyte stimulatory factor activity was sometimes present. Both activities were found to have a pI between pH 5.50 and 6.30. Detectable thymocyte stimulatory factor activity was found at concentrations as low as 0.1-0.2 ng of protein per 0.2 ml. Dose--response plots were linear up to at least 1 ng of protein. Preparations of interleukin 2 labeled with 125I-containing Bolton--Hunter reagent and purified by the procedure mentioned above were electrophoresed on a polyacrylamide gel under denaturing and reducing conditions. The 125I-labeled material migrated in one major band with a molecular weight under 20,000 and three smaller bands with molecular weights of about 20,000, 60,000, and 90,000. Material with thymocyte stimulatory factor activity did not bind to a number of lectin-gels.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Altin M., Di Sabato G. Multiple molecular forms of murine thymocyte-stimulating factor. Cell Immunol. 1980 Sep 1;54(2):462–470. doi: 10.1016/0008-8749(80)90226-9. [DOI] [PubMed] [Google Scholar]
- Altin M., Di Sabato G. Purification of murine thymocyte-stimulating factor from supernatants of mixed lymphocyte cultures. Cell Immunol. 1980 Sep 1;54(2):455–461. doi: 10.1016/0008-8749(80)90225-7. [DOI] [PubMed] [Google Scholar]
- Altman A., Katz D. H. Production and isolation of helper and suppressor factors. J Immunol Methods. 1980;38(1-2):9–41. doi: 10.1016/0022-1759(80)90328-2. [DOI] [PubMed] [Google Scholar]
- Bolton A. E., Hunter W. M. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. Biochem J. 1973 Jul;133(3):529–539. doi: 10.1042/bj1330529. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Caplan B., Gibbs C., Paetkau V. Properties of sodium dodecyl sulfate-denatured Interleukin 2. J Immunol. 1981 Apr;126(4):1351–1354. [PubMed] [Google Scholar]
- Chen D. M., Di Sabato G. Further studies on the thymocyte stimulating factor. Cell Immunol. 1976 Mar 15;22(2):211–224. doi: 10.1016/0008-8749(76)90024-1. [DOI] [PubMed] [Google Scholar]
- Di Sabato G., Chen D. M., Erickson J. W. Production by murine spleen cells of an activity stimulating the PHA-responsiveness of thymus lymphocytes. Cell Immunol. 1975 Jun;17(2):495–504. doi: 10.1016/s0008-8749(75)80053-0. [DOI] [PubMed] [Google Scholar]
- Evinger M., Rubinstein M., Pestka S. Growth-inhibitory and antiviral activity of purified leukocyte interferon. Ann N Y Acad Sci. 1980;350:399–404. doi: 10.1111/j.1749-6632.1980.tb20641.x. [DOI] [PubMed] [Google Scholar]
- Farrar J. J., Simon P. L., Koopman W. J., Fuller-Bonar J. Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. J Immunol. 1978 Oct;121(4):1353–1360. [PubMed] [Google Scholar]
- Frank M. B., Watson J., Mochizuki D., Gillis S. Biochemical and biologic characterization of lymphocyte regulatory molecules. VIII. Purification of interleukin 2 from a human T cell leukemia. J Immunol. 1981 Dec;127(6):2361–2365. [PubMed] [Google Scholar]
- GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gillis S., Ferm M. M., Ou W., Smith K. A. T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol. 1978 Jun;120(6):2027–2032. [PubMed] [Google Scholar]
- Gillis S., Henney C. S. The biochemical and biological characterization of lymphocyte regulatory molecules. VI. Generation of a B cell hybridoma whose antibody product inhibits interleukin 2 activity. J Immunol. 1981 May;126(5):1978–1984. [PubMed] [Google Scholar]
- Gillis S., Smith K. A., Watson J. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. J Immunol. 1980 Apr;124(4):1954–1962. [PubMed] [Google Scholar]
- Hübner L., Müller G., Schimpl A., Wecker E. Partial characterization and purification of murine T cell-replacing factor, TRF. II. Biochemical characteristics. Immunochemistry. 1978 Jan;15(1):33–39. doi: 10.1016/0161-5890(78)90023-8. [DOI] [PubMed] [Google Scholar]
- Mier J. W., Gallo R. C. Purification and some characteristics of human T-cell growth factor from phytohemagglutinin-stimulated lymphocyte-conditioned media. Proc Natl Acad Sci U S A. 1980 Oct;77(10):6134–6138. doi: 10.1073/pnas.77.10.6134. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mizel S. B., Farrar J. J. Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors. Cell Immunol. 1979 Dec;48(2):433–436. doi: 10.1016/0008-8749(79)90139-4. [DOI] [PubMed] [Google Scholar]
- Shaw J., Monticone V., Paetkau V. Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro. J Immunol. 1978 Jun;120(6):1967–1973. [PubMed] [Google Scholar]
- Smith K. A., Baker P. E., Gillis S., Ruscetti F. W. Functional and molecular characteristics of T-cell growth factor. Mol Immunol. 1980 May;17(5):579–589. doi: 10.1016/0161-5890(80)90156-x. [DOI] [PubMed] [Google Scholar]
- Watson J., Gillis S., Marbrook J., Mochizuki D., Smith K. A. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines. J Exp Med. 1979 Oct 1;150(4):849–861. doi: 10.1084/jem.150.4.849. [DOI] [PMC free article] [PubMed] [Google Scholar]
